INBRX-105
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INBRX-105, covering 2024-10-23 to 2024-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer [Phase 1]